Risk of anaphylactic reaction associated with glatiramer acetate, used to treat multiple sclerosis
Why it was recalled
Product safety - New safety information
What you should do
If you experience anaphylactic reaction symptoms, stop taking glatiramer acetate and seek immediate medical help by calling 9-1-1.Do not restart taking glatiramer acetate if you have experienced anaphylaxis unless your healthcare provider has identified another clear cause for the anaphylaxis.Report any health product-related side effects to Health Canada.What healthcare professionals should doInform patients and/or caregivers of the signs and symptoms of anaphylactic reactions, which may overlap with those of an immediate post-injection reaction.Instruct patients to seek immediate emergency medical care in the event of an anaphylactic reaction.Instruct patients to discontinue treatment with glatiramer acetate if they have an anaphylactic reaction.Do not restart the medicine unless there is another clear reason the patient experienced an anaphylactic reaction.
Other Recent Recalls
Apo-Semaglutide Injection
Apo-Semaglutide Injection : Incorrect dose display
Moderate health risk
Novo-Gesic Forte 500 mg tablets (acetaminophen)
Generic acetaminophen by Teva recalled because it may contain foreign material
Highest health risk
JAMP Temozolomide
JAMP Temozolomide: Out-of-Specification (Assay)
Moderate health risk
Recall data is sourced from Health Canada's Recalls and Safety Alerts open dataset. MedShort.ca is an independent tracking tool and does not provide medical advice — for questions about this recall, contact the manufacturer or your pharmacist, or read the full notice linked above.